Radiopharm Theranostics (PK)【RDPTF】銘柄情報

Radiopharm Theranostics Ltd (PK) (RDPTF) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.02

( - )

買値

0.0049

売値

1.51

出来高

0.00 日の範囲 0.00

0.019825 52 週間の範囲 0.02

時価総額

70.884M

前日終値

0.02

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 2,568,171

発行済株式数

3,544,216,160

配当利回り

PER

-1.05

1 株当たり利益 (EPS)

-0.02

歳入

16.28M

純利益

-46.58M

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain me... Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.radiopharmtheranostics.com

本社

Carlton, Australia

設立

2026

Radiopharm Theranostics Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker RDPTF. The last closing price for Radiopharm Theranostics (PK) was US$0.02. Over the last year, Radiopharm Theranostics (PK) shares have traded in a share price range of US$ 0.019825 to US$ 0.02.

Radiopharm Theranostics (PK) currently has 3,544,216,160 shares in issue. The market capitalisation of Radiopharm Theranostics (PK) is US$70.88 million. Radiopharm Theranostics (PK) has a price to earnings ratio (PE ratio) of -1.05.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 3 - Initial statement of beneficial ownership of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0.02	0.02	0.02	93333	0.02	CS
26	0	0	0.02	0.02	0.019825	11644378	0.01982559	CS
52	0	0	0.02	0.02	0.019825	4764609	0.01982563	CS
156	-0.065	-76.4705882353	0.085	0.3	0.0008	3085974	0.0198644	CS
260	-0.07	-77.7777777778	0.09	0.3	0.0008	2998089	0.01987109	CS